Editor's Note: This is Part Two of a three-part series highlighting several of the presentations from the American College of Cardiology’s Annual Scientific Session (ACC.26) that took place in March ...
May 10, 2026 — Results from the first randomized trial evaluating microRNA inhibition in heart failure were presented ...
May 7, 2026 — AccurKardia, a provider of ECG-based diagnostics technology, recently announced that AK+ Guard has been ...
May 1, 2026 — Echo IQ recently announced it has deployed its AI-based decision support software for the assessment of ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
May 7, 2026 — Bayer has announced positive topline results from the Phase III REVEAL study, an investigator-initiated ...
May 1, 2026 — Retia Medical recently announced the first public presentation of results from its non-invasive cardiac ...
May 6, 2026 — Image Analysis Group (IAG), a global imaging CRO headquartered in London, U.K., and HeartcoR Solutions ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
The clinical case for combining CT and angiography in a single workflow has been settled. Purpose-built mobile imaging ...
May 4, 2026 — Johnson & Johnson recently announced results from a novel U.S. pilot single-arm trial that evaluated the ...
May 4, 2026 — A new guideline from the American Society of Echocardiography (ASE) provides guidance for cardiovascular ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Could a link between the heart, brain and immune system help reduce the occurrence of heart attacks and lessen the ...
May 1, 2026 — On May 14, Cleerly and interventional cardiologist Neerav Sheth, MD, will present a free webinar on ...
April 29, 2026 — Agitated Solutions, Inc.(ASI) has received CE Mark approval in the European Union for its novel device ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Editor's Note: This is Part Two of a three-part series highlighting several of the presentations from the American ...
April 28, 2026 — Abbott has received U.S. Food and Drug Administration (FDA) clearance and CE Mark for its next ...
April 26, 2026 — New results from the multicenter catheter ablation versus anti-arrhythmic drugs for Ventricular ...
May 11, 2026
